<http://webisa.webdatacommons.org/prov/445525784>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/197404232> .
<http://webisa.webdatacommons.org/197404232>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<businesswire.com> .
<http://webisa.webdatacommons.org/197404232>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/197404232>	<http://www.w3.org/ns/prov#value>	"Medarex is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody-based therapeutics to treat life-threatening and debilitating diseases, including cancer, inflammation, autoimmune disorders and infectious diseases." .